Establishment of a Humanized APL Model via the Transplantation of PML-RARA-Transduced Human Common Myeloid Progenitors into Immunodeficient Mice

• Hiromichi Matsushita ,

  * E-mail: hmatsu@is.ic.cc.u-tokai.ac.jp (H. Matsushita); andok@keyaki.cc.u-tokai.ac.jp (KA)

  Affiliations Research Center for Cancer Stem Cell, Tokai University School of Medicine, Isehara, Kanagawa, Japan, Medical Research Institute, Tokai University, Isehara, Kanagawa, Japan, Department of Laboratory Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯
• Takashi Yahata,

  Affiliations Research Center for Cancer Stem Cell, Tokai University School of Medicine, Isehara, Kanagawa, Japan, Medical Research Institute, Tokai University, Isehara, Kanagawa, Japan, Department of Cell Transplantation, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯
• Yin Sheng,

  Affiliation Research Center for Cancer Stem Cell, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯
• Yoshihiko Nakamura,

  Affiliation Research Center for Cancer Stem Cell, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯
• Yukari Muguruma,

  Affiliation Research Center for Cancer Stem Cell, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯
• Hideyuki Matsuzawa,

  Affiliations Research Center for Cancer Stem Cell, Tokai University School of Medicine, Isehara, Kanagawa, Japan, Support Center for Medical Research and Education, Tokai University, Isehara, Kanagawa, Japan

  ⨯
• Masayuki Tanaka,

  Affiliation Support Center for Medical Research and Education, Tokai University, Isehara, Kanagawa, Japan

  ⨯
• Hideki Hayashi,

  Affiliation Support Center for Medical Research and Education, Tokai University, Isehara, Kanagawa, Japan

  ⨯
• Tadayuki Sato,

  Affiliation Support Center for Medical Research and Education, Tokai University, Isehara, Kanagawa, Japan

  ⨯
• Anar Damdinsuren,

  Affiliation Department of Laboratory Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯
• Makoto Onizuka,

  Affiliation Division of Hematology and Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯
• Mamoru Ito,

  Affiliation Central Institute for Experimental Animals, Kawasaki, Kanagawa, Japan

  ⨯
• Hayato Miyachi,

  Affiliation Department of Laboratory Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯
• Pier Paolo Pandolfi,

  Affiliation Cancer Research Institute, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Kiyoshi Ando

  * E-mail: hmatsu@is.ic.cc.u-tokai.ac.jp (H. Matsushita); andok@keyaki.cc.u-tokai.ac.jp (KA)

  Affiliations Research Center for Cancer Stem Cell, Tokai University School of Medicine, Isehara, Kanagawa, Japan, Medical Research Institute, Tokai University, Isehara, Kanagawa, Japan, Division of Hematology and Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan

  ⨯